Search Results - "Partin, A.W"

Very-high-risk Localized Prostate Cancer - Outcomes Following Definitive Radiation by Narang, A, Robertson, S.P, Ram, A.N, He, P, Sundi, D, Griffith, E, Singh, H, DeWeese, T, Honig, S, McNutt, T.R, Ross, A.E, Bivalacqua, T.J, Schaeffer, E.M, Partin, A.W, DeWeese, T.L, Song, D, Tran, P.T

Get full text

Multiple Intermediate-Risk Factors as a Prognostic Tool for Men With Localized Prostate Cancer by Ram, A.N, Narang, A.K, Robertson, S.P, He, P, Sundi, D, Griffith, E, Singh, H, DeWeese, T.A, Honig, S, McNutt, T.R, Schaeffer, E.M, Ross, A.E, Bivalacqua, T.J, Partin, A.W, Song, D.Y, Tran, P.T, DeWeese, T.L

Get full text

Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies by Hansel, D E, DeMarzo, A M, Platz, E A, Jadallah, S, Hicks, J, Epstein, J I, Partin, A W, Netto, G J

“…Early prostate cancer antigen is a nuclear matrix protein that was recently shown to be expressed in prostate adenocarcinoma and adjacent benign tissue…”
Get more information

Modulation of EPCA-2 Levels in Men with Localized Prostate Cancer Treated with Radiation with or without Androgen Suppression Therapy by Christodouleas, J.P, Yeater, D.B, Jabbour, S.K, Mangold, L, Leman, E.S, Drew, R, Humphreys, E, Partin, A.W, Getzenberg, R.H, DeWeese, T.L

Get full text

Machine Learning for the Prediction of Adverse Pathological Outcomes in Patients Treated with Radical Prostatectomy by Sabbagh, A., Tilki, D., Partin, A.W., Trock, B., Chen, M.H., Wu, J., DAmico, A.V., Mohamad, O.

“…Extracapsular extension (ECE) and seminal vesicle invasion (SVI) are associated with negative oncologic outcomes in patients with prostate cancer. We have…”
Get full text

Machine Learning for the Prediction of Biochemical Recurrence in Patients Treated with Radical Prostatectomy by Sabbagh, A., Trock, B., Partin, A.W., Wu, J., Chen, M.H., Tilki, D., DAmico, A.V., Mohamad, O.

“…Biochemical recurrence (BCR) occurs in about 40% of patients with prostate cancer following radical prostatectomy (RP). Our goal was to develop a machine…”
Get full text

Machine Learning for the Prediction of Lymph Node Metastasis in Patients with Prostate Cancer by Sabbagh, A., III, S. Washington, Tilki, D., Hong, J.C., Feng, J., Chen, M.H., Wu, J., Huland, H., Graefen, M., Wiegel, T., Böhmer, D., Cowan, J., Cooperberg, M.R., Feng, F.Y., Trock, B., Partin, A.W., DAmico, A.V., Carroll, P., Mohamad, O.

Get full text

Machine Learning for the Prediction of Distant Metastases Following Postprostatectomy Salvage Radiation Therapy by Sabbagh, A., Tilki, D., Feng, J., Hong, J.C., Chen, M.H., Wu, J., Huland, H., Graefen, M., Wiegel, T., Böhmer, D., Washington, S., Cowan, J., Cooperberg, M.R., Feng, F.Y., Carroll, P., Trock, B., Partin, A.W., DAmico, A.V., Mohamad, O.

Get full text

Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy by Schweizer, M.T., Zhou, X.C., Wang, H., Yang, T., Shaukat, F., Partin, A.W., Eisenberger, M.A., Antonarakis, E.S.

“…Clinical trials in men with biochemically recurrent prostate cancer (BRPC) have been hampered by long survival times, making overall survival (OS) a difficult…”
Get full text

In vivo measurement of tumor conductiveness with the magnetic bioimpedance method by Smith, D.G., Potter, S.R., Lee, B.R., Ko, H.W., Drummond, W.R., Telford, J.K., Partin, A.W.

“…A noninvasive electromagnetic method has been developed that can effectively measure the in-vivo conductivity difference between rat tumor lines having a low…”
Get full text

Very-high-risk localized prostate cancer: definition and outcomes by Sundi, D, Wang, V M, Pierorazio, P M, Han, M, Bivalacqua, T J, Ball, M W, Antonarakis, E S, Partin, A W, Schaeffer, E M, Ross, A E

“…Background: Outcomes in men with National Comprehensive Cancer Network (NCCN) high-risk prostate cancer (PCa) can vary substantially—some will have excellent…”
Get full text

431 Validation of the Decipher® prostate cancer classifier in intermediate to high risk men treated with radical prostatectomy but without additional therapy upon PSA rise by Ross, A, Johnson, M, Yousefi, K, Trock, B, Choeurng, V, Lam, L, Fedor, H.L, Ghadessi, M, Buerki, C, Glavaris, S, Sundi, D, Tosoian, J, Han, M, Humphreys, E.B, Partin, A.W, Netto, G.J, Davicioni, E, Schaeffer, E.M

Get full text

1003 IMPACT OF SURGICAL TECHNIQUE (OPEN VS. LAPAROSCOPIC VS. ROBOTIC-ASSISTED) ON PATHOLOGICAL AND BIOCHEMICAL OUTCOMES FOLLOWING RADICAL PROSTATECTOMY: AN ANALYSIS USING PROPENSITY SCORE MATCHING by Magheli, A, Gonzalgo, M.L, Su, L, Netto, G, Humphreys, E.B, Partin, A.W, Han, M, Pavlovich, C.P

Get full text

263 Development of novel PCA3 cut-offs for initial and repeat biopsy using different statistical approaches within a US-European multi institutional cohort by Auprich, M, Haese, A, De La Taille, A, Van, Poppel H, Marberger, M, Mulders, P.F.A, Abbou, C.C, Stillebroer, A.B, Van, Gils P.M.Q, Schalken, J.A, Stenzl, A, Fradet, Y, Marks, L.S, Ellis, W, Partin, A.W, Walz, J, Chun, F.K.H

Get full text

911 Biopsy-specific PCA3-based prostate biopsy nomograms are highly accurate by Chun, F.K, Hansen, J, De La Taille, A, Van Poppel, H, Marberger, M, Stenzl, A, Mulders, P.F.A, Huland, H, Abbou, C.C, Stillebroer, A.B, Van Gils, M.P.M.Q, Schalken, J.A, Fradet, Y, Marks, L.S, Ellis, W, Partin, A.W, Haese, A, Pummer, K, Auprich, M

Get full text

641 CRITICAL ASSESSMENT OF URINARY PROSTATE CANCER GENE 3 (PCA3) IN THE PREDICTION OF AGGRESSIVE PROSTATE CANCER (GLEASON score ≥ 7) AT BIOPSY by Auprich, M, Haese, A, De, La Taille A, Van Poppel, H, Marberger, M, Abbou, C.C, Stenzl, A, Mulders, P.F.A, Schalken, J.A, Huland, H, Stillebroer, A.B, Van, Gils P.M.Q, Fradet, Y, Marks, L.S, Ellis, W, Partin, A.W, Chun, F.K.H

Get full text

Fifth-Generation Digital Immunoassay for Prostate Specific Antigen Using Single Molecule Arrays by Wilson, D.H., Hanlon, D.W., Provuncher, G.K., Chang, L., Song, L., Patel, P.P., Ferrell, E.P., Lepor, H, Partin, A.W., Chan, D.W., Sokoll, L.J., Cheli, C.D., Thiel, R.P., Fournier, D.R., Duffy, D.C.

Get full text

The effect of hospital volume on cancer control after radical prostatectomy by Ellison, L M, Trock, B J, Poe, N R, Partin, A W

“…For complex oncological procedures, hospital volume affects short and long-term patient outcome. We examined the association of hospital volume and long-term…”
Get more information

Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF by Gretzer, M.B., Chan, D.W., van Rootselaar, C.L., Rosenzweig, J.M., Dalrymple, S., Mangold, L.A., Partin, A.W., Veltri, R.W.

“…Background Surface enhanced laser desorption and ionization‐time‐of‐flight (SELDI‐TOF) is an evolving proteomic technology for improving biomarker discovery…”
Get full text

Partin tables: past and present by Khan, M.A., Partin, A.W.

“…This is the start of a new section in the BJU International. The intention is to provide the reader with a series of review articles that are more focused than…”
Get full text